Avicenna Biosciences, Inc. — Form D

Avicenna Biosciences, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-14. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-09-14
Form: D
Accession: 0001824034-20-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $2.5M
Amount sold: $2.5M
Investors: 1
Date of first sale: 2020-08-28
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-375400

Issuer

Name: Avicenna Biosciences, Inc.
CIK: 0001824034
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 101 W. CHAPEL HILL STREET, SUITE 210, DURHAM, NC, 27701
Phone: 919-667-2504

Officers, directors & promoters (8)

Name	Role	Location
Pieter Burger	Director	Durham, NC
Pieter Burger	Executive Officer	Durham, NC
John Hamer	Director	Durham, NC
Dennis Langer	Director	Naples, FL
Thomas Kaiser	Director	Durham, NC
Thomas Kaiser	Executive Officer	Durham, NC
Christopher Meldrum	Director	Durham, NC
Christopher Meldrum	Executive Officer	Durham, NC

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2025-10-30	D/A	$71K	$71K
2024-07-16	D	$6.0M	$6.0M
2024-02-23	D	$10.0M	$6.0M
2023-03-22	D/A	$41K	$27K
2022-12-30	D	$6.0M	$3.0M
2022-10-27	D	$18K	$18K

More